Nanjing Pharmaceutical (600713.SH) released the third quarter report of 2024, with the company's revenue for the first three quarters reaching 40...
Zhithong Finance APP News, Nanjing Pharmaceutical (600713.SH) released the third quarter report of 2024, with the company's revenue for the first three quarters reaching 40.938 billion yuan, a year-on-year increase of 0.97%; net income attributable to shareholders of the listed company was 0.442 billion yuan, a year-on-year increase of 0.36%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.436 billion yuan, a year-on-year increase of 0.46%; basic earnings per share was 0.34 yuan/share.